Stories about: myelodysplastic syndrome

A prescription for bone marrow failure: Diagnose early, monitor often

A closeup illustration of cells in the bone marrow. (Gray's Anatomy via Wikimedia Commons)
A closeup illustration of cells in the bone marrow. (Gray’s Anatomy via Wikimedia Commons)

Akiko Shimamura, MD, PhD, first became fascinated with hematology as a pediatric resident at Johns Hopkins Hospital, an interest that blossomed into a career dedicated to the study and treatment of bone marrow failure (BMF) syndromes, first at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and then at Seattle Children’s Hospital/Fred Hutchinson Cancer Research Center. Last fall, she moved back to Boston to take the helm of the Bone Marrow Failure (BMF) Program at Dana-Farber/Boston Children’s, bringing with her a perspective on pediatric BMF/myelodysplastic syndrome (MDS) that centers on collaboration as a path to deeper understanding of BMF/MDS biology and an approach to patient care.

Notes invited Shimamura to talk about her thoughts on the current and future state of BMF/MDS research and management. Below is a summary transcript of what she had to say. …Read More

Read Full Story | Leave a Comment